ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2010
Mycoviruses: future therapeutic agents of invasive fungal infections in humans?
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Tracking of Tobacco Mosaic Virus in Taxonomically Different Plant Fungi.Journal of fungi (Basel, Switzerland) · 2025Article
- The Expanding Mycovirome ofJournal of fungi (Basel, Switzerland) · 2024Review
- An Overview of Mycoviral Curing Strategies Used in Evaluating Fungal Host Fitness.Molecular biotechnology · 2023Review
- The intriguing phenomenon of cross-kingdom infections of plant and insect viruses to fungi: Can other animal viruses also cross-infect fungi?PLoS pathogens · 2023Article
- Review
- Invasive Fungal Infections after Liver Transplantation.Journal of clinical medicine · 2023Review
- Detection of the Xanthi Chryso-like Virus in New Geographical Area and a Novel Arthropod Carrier.Tropical medicine and infectious disease · 2023Article
- Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles.Microbiology spectrum · 2023Article
- Polymycovirus Infection SensitizesViruses · 2023Article
- Human Clinical Isolates of Pathogenic Fungi Are Host to Diverse Mycoviruses.Microbiology spectrum · 2022Article
- Deoxynivalenol Biosynthesis inToxins · 2022Article
- A Satellite dsRNA Attenuates the Induction of Helper Virus-Mediated Symptoms inFrontiers in microbiology · 2022Article
- Virus Infection ofViruses · 2021Article
- Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?Antibiotics (Basel, Switzerland) · 2020Review
- Phenotypic and Molecular Biological Analysis of Polymycovirus AfuPmV-1M FromFrontiers in microbiology · 2020Article
- Understanding Mucormycoses in the Age of "omics".Frontiers in genetics · 2020Review
- Molecular Characterization of a Debilitation-Associated Partitivirus Infecting the Pathogenic FungusFrontiers in microbiology · 2019Article
- Article
- A novel chrysovirus from a clinical isolate of Aspergillus thermomutatus affects sporulation.PloS one · 2018Article
- Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosa.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive fungal infections are relatively common opportunistic infections in immunocompromised patients and are still associated with a high mortality rate. Furthermore, these infections are often complicated by resistance or refractoriness to current antimicrobial agents. Therefore, an urgent need exists for new therapeutic strategies based on the identification of new microbial targets and novel antimicrobial agents. One such hypothetical therapeutic strategy may involve the use of mycoviruses that are able to selectively infect fungi. Current knowledge of mycoviruses of human pathogenic fungi and the scope for using (recombinant) mycoviruses as future biological control agents are reviewed here.
Indexed as
Identifiers
20437251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.